Skip to main content
BIONEERCORPORATION logo

BIONEERCORPORATION — Investor Relations & Filings

Ticker · 064550 ISIN · KR7064550007 KO Manufacturing
Open in API
Filings indexed 280 across all filing types
Latest filing 2026-01-08 Major Shareholding Noti…
Country KR South Korea
Listing KO 064550

About BIONEERCORPORATION

https://eng.bioneer.com/

Bioneer Corporation is a biotechnology company that develops and manufactures molecular biology products, technologies, and services for the life science research and molecular diagnostics markets. The company's portfolio includes a range of instruments, such as conventional and real-time PCR systems, and patented auxiliary devices for sample preparation. Bioneer provides integrated solutions for molecular diagnostics, offering kits for various infectious diseases. Additionally, it offers custom services including oligo and gene synthesis. The company's research and development efforts also focus on siRNA technologies and drug delivery systems.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed with the Financial Supervisory Service (FSS) and Korea Exchange. It details changes in share ownership by major shareholders and special related parties, including specific share counts, percentages, and reasons for changes (such as employee stock ownership withdrawals and collateral release). This type of filing is a standard regulatory disclosure for significant ownership changes, which falls under the 'Major Shareholding Notification' category.
2026-01-08 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Interim / Quarterly Report Classification · 95% confidence The document is titled as a preliminary (잠정) consolidated operating performance report for a specific quarter (2025 Q3) and includes detailed financial figures such as sales, operating profit, and net income for the current and previous periods. It explicitly states that the figures are provisional and prepared under Korean IFRS, and it is intended for investors. The document length is 2491 characters, which is relatively short but contains substantive financial data, not just an announcement or a link to a report. It is not a full annual report but a quarterly or interim financial performance update. Therefore, it fits the definition of an Interim / Quarterly Report (IR). 9M 2025
2025-10-31 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 95% confidence The document is a notification regarding the appointment, dismissal, or mid-term resignation of an outside director (사외이사) of the company (주)바이오니아. It includes details about the change in the number and ratio of outside directors, the resignation date, and compliance with relevant laws. The document is addressed to regulatory bodies (Financial Services Commission/Korea Exchange) and serves as an official announcement of board member changes. It does not contain financial statements, audit information, or other report types. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and focused on management changes, confirming this classification with high confidence.
2025-10-16 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard regulatory filing in South Korea (often referred to as an 'Insider Trading Report' or 'Director's Dealing' report) where company executives disclose changes in their shareholdings. Based on the provided definitions, this falls under 'Director's Dealing' (DIRS).
2025-09-17 Korean
반기보고서 (2025.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for the company 'Bioneer' covering the period from January 1, 2025, to June 30, 2025. It contains detailed business descriptions, financial information, management discussions, and corporate governance details. This document is a comprehensive financial report for a period shorter than a full fiscal year, which fits the definition of an Interim/Quarterly Report (IR). H1 2025
2025-08-14 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Provisional Earnings Release' (영업(잠정)실적) for Bioneer, detailing quarterly financial performance (revenue, operating profit, net income) for the 2nd quarter of 2025. It explicitly states these are preliminary figures (잠정치) and not yet audited. This fits the definition of an Earnings Release (ER), which provides key financial highlights for a specific period. Q2 2025
2025-07-31 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.